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Identity 
Note: Not to be confused with the t(11;17)(q23;q12-21) involving MLL and LASP1 or the t(11;17)(q23;q12-21) 
involving MLL and ACACA. 
 
 
t(11;17)(q23;q12) G-banding - Courtesy Cytogenetics Laboratory of the CCRI, Children's Cancer Research Institute, Vienna. 
 
Clinics and pathology 
Disease 
Acute myeloid leukemia (AML). 
Epidemiology 
Not sufficient cases to date. 
Cytogenetics 
Note: so far three MLL fusion partners, namely 
LASP1, AF17 (alias MLLT6), and ACACA have been 
identified in 17q12-21; these translocations cannot be 
distinguished cytogenetically and the accurate detection 
of the specific fusion gene requires RT-PCR or refined 
FISH analysis. 
Cytogenetics molecular 
Chromosomes (arrows on the figure below). 
Probes 




Genes involved and Proteins 
MLL 
Location: 11q23 
DNA / RNA 
37 exons, spanning over 100 kb; transcription in a 
centromeric to telomeric direction; 13 -15 kb mRNA; 
coding sequence 11.9 kb. 
Protein 
431 kDa; contains two DNA binding motifs (an AT 
hook, and Zinc fingers), a DNA methyl transferase 
motif, and a bromodomain; transcriptional regulatory 
factor; nuclear localization. 
MLLT6 (alias AF17) 
Location: 17q12 
Note: previously LASP1 and AF17 (alias MLLT6) 
were mapped to 17q21, but according to the most 
recent genome assembly built by the Genome 
Bioinformatics Group of the University of California 
Santa Cruz and recent FISH data both genes are 
localized in 17q12 and proximal to RARA. 
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FISH using a combination of the MLL-specific PACs 217a21 and 167k13 (green signals) and the AF17-specific BAC RP11-25H10 (red 




Schematic representation of MLL, AF17 (alias MLLT6), and the putative MLL-AF17 fusion protein. MT, methyltransferase domain; Zn 
finger, Zinc finger domain; SET-domain; PHD, Zinc finger PHD-type; OM, octapeptide motif; LZ, leucine-zipper dimerization motif. 
 
DNA / RNA 
Encompasses 19.97 kb of genomic DNA; 4914 bp 
mRNA; 20 exons, 3282 bp coding sequence. 
Protein 
1023 amino acids, 112 kDa; MLLT6 (alias AF17), 
MLLT10 (alias AF10), and BRPF1 (alias BR140) 
belong to a small evolutionary highly conserved family 
of putative nuclear transcription factors, which contain 
amino-terminal PHD fingers, a highly conserved 
octapeptide, and a classical leucine zipper dimerization 
motif; nuclear localization. 




5' MLL - 3' AF17 
Fusion protein 
Description 
The AT-hook DNA-binding domain and the 
methyltransferase motif including the CXXC zinc-
finger (Zn) domain of MLL are fused to the highly 
conserved octapeptide (OM) and the leucine-zipper 
(LZ) dimerization motif of AF17 (alias MLLT6). 
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